XML 42 R27.htm IDEA: XBRL DOCUMENT v3.25.0.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2024
Summary of Significant Accounting Policies [Abstract]  
Schedule of Accounts and Grants Receivable

Accounts and grants receivable by source, as of (in thousands):

 

 

December 31,

 

 

2024

 

 

2023

 

Accounts receivables from customers

 

$

25

 

 

$

15

 

National Institutes of Health – Grant

 

 

59

 

 

 

96

 

Total

 

$

84

 

 

$

111

 

 

Schedule of Revenue

Revenue by source (in thousands):

 

 

Year Ended
December 31,

 

 

2024

 

 

2023

 

Clinical trial revenue

 

$

1,402

 

 

$

668

 

Contract manufacturing lease revenue

 

 

503

 

 

 

-

 

Contract manufacturing revenue

 

 

487

 

 

 

-

 

National Institute of Health - grant

 

 

-

 

 

 

41

 

Total

 

$

2,392

 

 

$

709